Showing 3,741 - 3,760 results of 18,480 for search 'significantly ((((((a decrease) OR (linear decrease))) OR (mean decrease))) OR (greatest decrease))', query time: 0.47s Refine Results
  1. 3741

    Patient characteristics and procedural data. by Jonathan Nadjiri (665209)

    Published 2024
    “…The activation algorithm utilizing the emergency phone led to a slight decrease in radiation doses and fluoroscopy time and a significant reduction (15min) in diagnosis to treatment intervals (p = 0.019). …”
  2. 3742

    GLM models for predictors of monthly HIV costs. by Drew B. Cameron (10687420)

    Published 2024
    “…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …”
  3. 3743

    Median cost (USD) per visit breakdown. by Drew B. Cameron (10687420)

    Published 2024
    “…<div><p>Background</p><p>Despite improvements to the cascade of HIV care in East Africa, access to care for non-communicable disease co-morbidities like hypertension (HTN) remains a persistent problem. The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. …”
  4. 3744
  5. 3745
  6. 3746
  7. 3747
  8. 3748
  9. 3749
  10. 3750
  11. 3751
  12. 3752
  13. 3753
  14. 3754
  15. 3755
  16. 3756
  17. 3757

    Table 1_Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial.d... by Takeshi Osonoi (1951555)

    Published 2025
    “…While HbA1c and GA decreased and 1,5-AG increased one month after imeglimin initiation, GA and 1,5-AG showed rapid changes compared to the gradual decrease in HbA1c. …”
  18. 3758
  19. 3759
  20. 3760

    Table 1_Atractylenolide-I restore intestinal barrier function by targeting the S100A9/AMPK/mTOR signaling pathway.xlsx by Chen Chen (6544)

    Published 2025
    “…Transcriptomic analysis revealed that AT-1 significantly modulated the expression of S100A8 and S100A9. …”